Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News

12:23 EDT 25th April 2017 | BioPortfolio

Showing News Articles 1–25 of 890,000+

Tuesday 25th April 2017

Human medicines European public assessment report (EPAR): Soliris, eculizumab, Revision: 20, Authorised

Resolutions Submitted to Ipsen’s Shareholders’ Meeting on June 7, 2017

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) announces the publication of the resolutions proposed by its Board of Directors to its next Shareholders’ Meeting to be held on June 7, 2017 at 3:00 pm at the Maison des Arts et Métiers in Paris in the Bulletin des annonces légales obligatoires. In addition to the dividend approval (...

Transgene: €50.7 Million in Cash and Cash Equivalents as of March 31, 2017

3 new clinical trials launched since the beginning of 2017 New clinical collaboration with Bristol-Myers Squibb to evaluatea TG4010 combination as first-line treatment in lung cancer Cash burn in line with expectations Regulatory News: Transgene (Paris:TNG), a biotech company that designs and dev...

ChemChina Reconfirms Timeline for Public Offers for Syngenta Shares and ADSs

In response to speculation in the market, ChemChina today reconfirmed on behalf of the Offeror that all regulatory approvals and conditions required for the closing of the offers have been obtained or satisfied. Subject to at least 67% of Syngenta’s issued shares and ADSs being validly tendered into the offers and not withdrawn as of May 4, 2017, the Off...

Saudi Arabia serialization rules prompt Recipharm investment; US plant open

Drug track and trace rules introduced in Saudi Arabia prompted a €300,000 ($326,078) investment in processing technology and software according to Sweden-based contractor Recipharm.

Median Technologies is Awarded the 2017 Tech 40 Label and Joins EnterNext Tech 40 Index

Tech 40 Index includes top-performing Tech companies listed on the Euronext Regulatory News: Median Technologies (Paris:ALMDT) (ALMDT:PA), the Imaging Phenomics Company™, today announces that it has been awarded the 2017 Tech 40 Label, and is now included in the EnterNext Tech 40 Index. The Tech 40 Label is an initiative laun...

ProRehab Physical Therapy Sponsoring Derby City CrossFit

Staff to provide prevention and recovery services; focus on improving speed and agility of athletes Louisville, KY (PRWEB) April 25, 2017 ProRehab Physical Therapy (PRPT) is pleased to announce they have signed an agreement to be the preferred physical therapy provider for Derby City CrossFit, effective immediately. In addition to treating athletes with injuries and returning them to Derby City C...

Q-nomy to Unveil Q-Flow® Video Interaction Manager for Telehealth at UK e-Health Week 2017

Q-Flow's latest version now adds managed video interactions to multi-channel patient journeys Q-nomy, a leading global provider of patient journey and throughput optimization solutions, today announced it will unveil its newest addition to the Q-Flow version 6 platform - Q-Flow Video Interaction Manager, an application for performing video interactions...

Click Therapeutics Announces Multiple Publications of Clinical Data Supporting Digital Therapeutics™ Programs for Smoking Cessation and Major Depressive Disorder

Efficacy results of Click’s patent-pending cognitive-emotional digital therapeutic for major depressive disorder to be presented at the Society of Biological Psychiatry Annual Scientific Convention in San Diego, CA on May 19, 2017. Results of a 416-person clinical trial of Clickotine® for smoking cessation published in JM...

Provista and GeriMed Create Strategic Partnership to Improve Purchasing Power for Long-Term Care Pharmacies

Provista, a proven leader in the supply chain industry since 1994, today announced a new strategic partnership with GeriMed, a pharmacy group purchasing organization that works to impr

Oncology Consultants Selects Navigating Cancer Technology to Move Value-Based Initiatives to the Next Level

Leading provider of patient relationship management for oncology patient care is proud to partner with Houston’s leading cancer care provider Seattle, WA (PRWEB) April 25, 2017 Navigating Cancer and Oncology Consultants are excited to announce their new partnership to implement Navigating Cancer’s technology platform. The platform will give Oncology Consultants’ care team new tools to deliv...

‘Unprecedented’ numbers of UK cancer cases over past five years, new analysis shows

The number of people diagnosed with cancer each year in the UK has increased by more than 25,000 in the last five years, new analysis from Macmillan Cancer Support shows. Macmillan says that this increase is putting the NHS under more pressure than ever...

MPIRICA Health raises $4.6M for transparency tools to support procedure venue decisions

MPIRICA Health is one of 24 healthcare companies that OurCrowd has invested in since January last year.

2017 Sterile Processing State of the Industry Report

This year's state of the industry report on sterile processing, with data provided through an online survey of ICT readers who work in sterile processing departments (SPDs) and central sterile supply departments (CSSDs), is designed to offer a snapshot of the key issues and challenges relating to budgets, resourcing and workloads, as well as human

Researchers Identify HCV Infection Clusters

Hepatitis C virus (HCV) infections have increased during the past decade but little is known about geographic clustering patterns. Stopka, et al. (2017) used a unique analytical approach, combining geographic information systems (GIS), spatial epidemiology, and statistical modeling to identify and characterize HCV hotspots, statistically

Study Reveals Impact of Unethical Behavior on an Individual, According to Research from Oklahoma State University

We hear about business scandals all the time, from Wells Fargo creating fake bank accounts to increase profits to Hampton Creek’s inflated sales numbers. But what happens to us morally after we do something wrong? Oklahoma State University associate professor of management Rebecca Greenbaum with co-authors and former OSU PhD students Julena Bonner, ...

Cipher Pharmaceuticals Inc CPH Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 10032017] Prices from USD $250

SummaryCipher Pharmaceuticals Inc Cipher is a pharmaceutical company that develops skin care solutions. The company's major products include Actikerall, indicated for the treatment of hyperkeratotic actinic keratosis; Beteflam, a topical patch used for the treatment of mild to moderate plaque psoriasis; Epuris, an oral retinoid which is indicated for the treatment of severe nodular and inflammator...

Human medicines European public assessment report (EPAR): Xgeva, denosumab, Revision: 10, Authorised

Mark Dogadalski Joins HealthFitness as Chief Operations Officer

Industry veteran to bring track record of strategic and operational accomplishments to leadership team HealthFitness is pleased to announce that Mark Dogadalski has joined as its Chief Operations Officer. In this role, Dogadalski will oversee, develop and set the strategic direction for the operations of HealthFitness and work to enhance client satisfa...

Nemaura Medical Inc. Successfully Completes Development of Second-Generation sugarBEAT® Non-Invasive Continuous Glucose Monitoring Skin-Patch.

Nemaura Medical Inc. (OTCBB: NMRD), a medical device company has today announced the successful completion of the development and testing of its second-generation sugarBEAT® wireless skin-patch as a non-invasive, needle-free Continuous Glucose Monitoring (CGM) system for use by diabetics. The first-generation sugarBEAT® received CE approval in Q1 2016, a...

Humacyte Founder Laura Niklason, M.D., Ph.D. Recognized on Fortune Magazine’s List of Leaders Transforming Health and Medicine

Honored for Innovative Contributions to the Advancement of Regenerative Medicine Humacyte, an innovator in biotechnology and regenerative medicine, announced today that Fortune Magazine has recognized Company founder Laura Niklason, M.D., Ph.D., as a leading change agent in healthcare, on Fortune’s

Human medicines European public assessment report (EPAR): HyQvia, human normal immunoglobulin, Revision: 9, Authorised

Telehealth a key component in healthcare transformation

As healthcare continues its transformation in today’s digital world, telehealth plays a crucial role. Telemedicine leaders share their insights.

Omniox Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 21022017] Prices from USD $250

SummaryOmniox Inc Omniox is a biopharmaceutical company that develops new medicines for hypoxic diseases. The company offers HNOX product tailored for the treatment of hypoxic cancers, which include giloblastoma, metastatic brain cancer, headandneck cancer, pancreatic cancer, lung cancer, and prostate cancer in combination with standard of care radiation and chemotherapy. It provides engineering o...

GE Global Research Medical Equipment Deals and Alliances Profile [Updated: 14032017] Prices from USD $250

SummaryGE Global Research GE Global is a research and development company. The company offers research and development services in various industry sectors. Its diverse technologies are used in electronics, chemistry, biosciences, computing, metallurgy, fluid mechanics, materials imaging, and other applications. GE Global also develops technologies to extract new shale gas and tight oil reserves o...


Quick Search
Advertisement
 

BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device information service collates press releases, news articles and blogs from over 275 sources.